Emerging concepts in the science of vaccine adjuvants

2021/04/06 by Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan · 13 citations
Immunology and Microbiology · Medicine · #Immune responses and vaccinations #Immunotherapy and Immune Responses #SARS-CoV-2 and COVID-19 Research

paper · pdf · doi:10.1038/s41573-021-00163-y

crossref issued 2021/04/06 · crossref published 2021/04/06 · crossref published-online 2021/04/06 · openalex publication_date 2021/04/06 · crossref created 2021/04/06 · crossref published-print 2021/06/01 · crossref deposited 2023/11/01 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Advances in the structure-based design of protein vaccines for respiratory infectious diseases
• Diverse priming outcomes under conditions of very rare precursor B cells
• A Versatile Polymer‐Based In Situ Nanovaccine to Boost Cancer Immunotherapy
• Transforming vaccinology
• Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies
• Global vaccine development
• Određivanje kiselosti mlijeka
• Polymeric Nanoparticles for Drug Delivery
• A photoactivatable tumor‐targeting in situ nanovaccine for large‐volume tumor therapy
• Suspension stability of aluminum-based adjuvants
• Non-clinical toxicology of therapeutic vaccines: Regulatory considerations and species selection: A comprehensive review
• System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
• COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
• Investigation of physical mixtures versus disulfide crosslinking self-adjuvanting peptide-based subunit vaccines against Group A Streptococcus